Subfertility Clinical Trial
Official title:
A Retrospective Cohort Study of Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire (UHCW)
Hyperprolactinaemia and thyroid disorders can significantly reduce fertility by causing
ovulatory dysfunction. There is no evidence to suggest treatment of hyperprolactinaemia in
the presence of regular ovulatory menstruation will improve fertility. However, anecdotal
observation of practice at UHCW NHS Trust suggested that dopamine agonists are often
prescribed irrespective of whether symptoms of hyperprolactinaemia are present.
The aim of the study was to establish the prevalence of hyperprolactinaemia and incidence of
subclinical hypothyroidism in patients undergoing subfertility investigations at UHCW NHS
Trust. Also, to examine management of patients with hyperprolactinaemia and a normal
pituitary MRI scan, and explore the trends in treatment; and finally, to explore how this
could improve reproductive services.
107 patients were identified as having a high prolactin reading between January 2014 and
January 2017. Hospital records were examined for patient demographics, relevant blood and
scan results, medical history, any treatment, and treatment outcomes.
The prevalence of hyperprolactinaemia was 23%. 20.6% of patients had suboptimal thyroid
function and were started on levothyroxine. Prolactin levels, and presence of relevant
symptoms, only had a partial bearing on whether dopamine agonists were used in those with
normal pituitary MRI results (or where no scan was performed). The use of dopamine agonists
appeared to correlate with assisted conception and a lower incidence of birth complications
(inc. miscarriage, prematurity), though the significance of this was limited by the size of
the dataset.
Dopamine agonists often appeared to be used in more complex patients, rather than exclusively
those with a higher prolactin reading and/or the presence of related symptomatology. Patients
frequently underwent a pituitary MRI scan in the absence of symptoms, contrary to evidence.
The findings suggest that less patients should be scanned and less treated with dopamine
agonists. A health economics evaluation study would be useful to elucidate the potential cost
saving this could represent. It may be better to prioritise optimisation of thyroid function,
particularly when noting the similarities in the prevalence of suboptimal thyroid function
and that of hyperprolactinaemia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03105453 -
The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
|
||
| Terminated |
NCT02180256 -
Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial
|
N/A | |
| Terminated |
NCT02197832 -
A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles
|
N/A | |
| Completed |
NCT00971152 -
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
|
Phase 3 | |
| Completed |
NCT01569945 -
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
|
N/A | |
| Recruiting |
NCT04064840 -
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
|
Phase 3 | |
| Recruiting |
NCT02561793 -
DHEA Versus Placebo in Women With Poor Ovarian Response
|
Phase 3 | |
| Terminated |
NCT02570386 -
Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer
|
N/A | |
| Completed |
NCT02197208 -
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
|
N/A | |
| Completed |
NCT01961336 -
Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF
|
Phase 3 | |
| Completed |
NCT02487940 -
Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure
|
Phase 4 | |
| Completed |
NCT01385618 -
Gene-polymorphisms Relating to Human Subfertility
|
N/A | |
| Completed |
NCT00985062 -
Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization
|
N/A | |
| Recruiting |
NCT04538560 -
Preimplantation Genetic Testing for Aneuploidy of Polar Bodies
|
N/A | |
| Completed |
NCT02748278 -
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
|
||
| Completed |
NCT02044445 -
Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?
|
N/A | |
| Completed |
NCT02863614 -
Analgesia for Endometrial Scratching
|
N/A | |
| Completed |
NCT02154958 -
Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility
|
N/A | |
| Completed |
NCT02151006 -
Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
|
Phase 3 | |
| Completed |
NCT01067664 -
Prognostic Value of Progesterone for In Vitro Fertilization (IVF) Outcome
|
N/A |